155 related articles for article (PubMed ID: 15490768)
1. [Acamprosate--new preclinical research aspects].
Spanagel R; Mann K
MMW Fortschr Med; 2003 Oct; 145 Suppl 3():61-4. PubMed ID: 15490768
[TBL] [Abstract][Full Text] [Related]
2. Interactions between ethanol and agents that act on the NMDA-type glutamate receptor.
Lovinger DM
Alcohol Clin Exp Res; 1996 Nov; 20(8 Suppl):187A-191A. PubMed ID: 8947262
[No Abstract] [Full Text] [Related]
3. Mechanism of action of acamprosate. Part II. Ethanol dependence modifies effects of acamprosate on NMDA receptor binding in membranes from rat cerebral cortex.
al Qatari M; Bouchenafa O; Littleton J
Alcohol Clin Exp Res; 1998 Jun; 22(4):810-4. PubMed ID: 9660305
[TBL] [Abstract][Full Text] [Related]
4. Potential neuroprotective effects of acamprosate.
Koob GF; Mason BJ; De Witte P; Littleton J; Siggins GR
Alcohol Clin Exp Res; 2002 Apr; 26(4):586-92. PubMed ID: 11981137
[TBL] [Abstract][Full Text] [Related]
5. [Glutamate receptor agonists and alcohol dependence. Preclinical findings].
Spanagel R; Kornhuber J
Nervenarzt; 1999 May; 70(5):479-81. PubMed ID: 10407846
[No Abstract] [Full Text] [Related]
6. Acamprosate enhances N-methyl-D-apartate receptor-mediated neurotransmission but inhibits presynaptic GABA(B) receptors in nucleus accumbens neurons.
Berton F; Francesconi WG; Madamba SG; Zieglgänsberger W; Siggins GR
Alcohol Clin Exp Res; 1998 Feb; 22(1):183-91. PubMed ID: 9514305
[TBL] [Abstract][Full Text] [Related]
7. Acamprosate is neuroprotective against glutamate-induced excitotoxicity when enhanced by ethanol withdrawal in neocortical cultures of fetal rat brain.
al Qatari M; Khan S; Harris B; Littleton J
Alcohol Clin Exp Res; 2001 Sep; 25(9):1276-83. PubMed ID: 11584146
[TBL] [Abstract][Full Text] [Related]
8. The effects of acamprosate and neramexane on cue-induced reinstatement of ethanol-seeking behavior in rat.
Bachteler D; Economidou D; Danysz W; Ciccocioppo R; Spanagel R
Neuropsychopharmacology; 2005 Jun; 30(6):1104-10. PubMed ID: 15668725
[TBL] [Abstract][Full Text] [Related]
9. Acamprosate. A review of its pharmacology and clinical potential in the management of alcohol dependence after detoxification.
Wilde MI; Wagstaff AJ
Drugs; 1997 Jun; 53(6):1038-53. PubMed ID: 9179530
[TBL] [Abstract][Full Text] [Related]
10. Pharmacology of acamprosate: an overview.
Zornoza T; Cano MJ; Polache A; Granero L
CNS Drug Rev; 2003; 9(4):359-74. PubMed ID: 14647529
[TBL] [Abstract][Full Text] [Related]
11. Acamprosate produces its anti-relapse effects via calcium.
Spanagel R; Vengeliene V; Jandeleit B; Fischer WN; Grindstaff K; Zhang X; Gallop MA; Krstew EV; Lawrence AJ; Kiefer F
Neuropsychopharmacology; 2014 Mar; 39(4):783-91. PubMed ID: 24081303
[TBL] [Abstract][Full Text] [Related]
12. Acamprosate: a prototypic neuromodulator in the treatment of alcohol dependence.
Mason BJ; Heyser CJ
CNS Neurol Disord Drug Targets; 2010 Mar; 9(1):23-32. PubMed ID: 20201812
[TBL] [Abstract][Full Text] [Related]
13. The clinical pharmacology of acamprosate.
Kalk NJ; Lingford-Hughes AR
Br J Clin Pharmacol; 2014 Feb; 77(2):315-23. PubMed ID: 23278595
[TBL] [Abstract][Full Text] [Related]
14. Biphasic effect of acamprosate on NMDA but not on GABAA receptors in spontaneous rhythmic activity from the isolated neonatal rat respiratory network.
Pierrefiche O; Daoust M; Naassila M
Neuropharmacology; 2004 Jul; 47(1):35-45. PubMed ID: 15165832
[TBL] [Abstract][Full Text] [Related]
15. Interaction of acamprosate with ethanol and spermine on NMDA receptors in primary cultured neurons.
Popp RL; Lovinger DM
Eur J Pharmacol; 2000 Apr; 394(2-3):221-31. PubMed ID: 10771287
[TBL] [Abstract][Full Text] [Related]
16. Acamprosate: recent findings and future research directions.
Mann K; Kiefer F; Spanagel R; Littleton J
Alcohol Clin Exp Res; 2008 Jul; 32(7):1105-10. PubMed ID: 18540918
[TBL] [Abstract][Full Text] [Related]
17. The effect of acamprosate on the development of morphine-induced behavioral sensitization in rats.
Kratzer U; Spanagel R; Schmidt WJ
Behav Pharmacol; 2003 Jul; 14(4):351-6. PubMed ID: 12838041
[TBL] [Abstract][Full Text] [Related]
18. The influence of various glutamate receptors antagonists on anxiety-like effect of ethanol withdrawal in a plus-maze test in rats.
Kotlinska J; Bochenski M
Eur J Pharmacol; 2008 Nov; 598(1-3):57-63. PubMed ID: 18838071
[TBL] [Abstract][Full Text] [Related]
19. [Prevention of recurrent alcoholism with acamprosate. Neurobiological principles and clinical results].
Soyka M; Zieglgänsberger W
Internist (Berl); 1999 Mar; 40(3):330-6. PubMed ID: 10205765
[No Abstract] [Full Text] [Related]
20. Acamprosate inhibits Ca2+ influx mediated by NMDA receptors and voltage-sensitive Ca2+ channels in cultured rat mesencephalic neurones.
Allgaier C; Franke H; Sobottka H; Scheibler P
Naunyn Schmiedebergs Arch Pharmacol; 2000 Nov; 362(4-5):440-3. PubMed ID: 11111840
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
